These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30989475)

  • 1. SIRT6 abrogation promotes adrenocortical carcinoma through activation of NF-κB signaling.
    Wu X; Tian H; Xue L; Wang L
    Mol Cell Biochem; 2019 Aug; 458(1-2):1-10. PubMed ID: 30989475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin6 inhibits c-triggered inflammation through TLR4 abrogation regulated by ROS and TRPV1/CGRP.
    Zhang R; Li H; Guo Q; Zhang L; Zhu J; Ji J
    J Cell Biochem; 2018 Nov; 119(11):9141-9153. PubMed ID: 30105859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
    Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
    Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BaZiBuShen alleviates altered testicular morphology and spermatogenesis and modulates Sirt6/P53 and Sirt6/NF-κB pathways in aging mice induced by D-galactose and NaNO
    Li L; Chen B; An T; Zhang H; Xia B; Li R; Zhu R; Tian Y; Wang L; Zhao D; Mo F; Li Y; Yang G; Orekhov AN; Prentki M; Zhang D; Jiang G; Zhu X
    J Ethnopharmacol; 2021 May; 271():113810. PubMed ID: 33508368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.
    Liu-Chittenden Y; Jain M; Gaskins K; Wang S; Merino MJ; Kotian S; Kumar Gara S; Davis S; Zhang L; Kebebew E
    Oncogene; 2017 Jun; 36(25):3541-3552. PubMed ID: 28114280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
    Yan ZC; He L; Qiu JH; Deng WT; Lu JR; Yuan Z; Liu DJ; Zheng RQ; Jiang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6640-6649. PubMed ID: 30402836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumors.
    Kanczkowski W; Tymoszuk P; Ehrhart-Bornstein M; Wirth MP; Zacharowski K; Bornstein SR
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E421-9. PubMed ID: 20826579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span.
    Kawahara TL; Michishita E; Adler AS; Damian M; Berber E; Lin M; McCord RA; Ongaigui KC; Boxer LD; Chang HY; Chua KF
    Cell; 2009 Jan; 136(1):62-74. PubMed ID: 19135889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
    Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A; Min IM; Crowley MJP; Panjwani SJ; Finnerty BM; Scognamiglio T; Liu YF; Whitsett TG; Garg S; Demeure MJ; Elemento O; Zarnegar R; Fahey TJ
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin-6 deficiency exacerbates diabetes-induced impairment of wound healing.
    Thandavarayan RA; Garikipati VN; Joladarashi D; Suresh Babu S; Jeyabal P; Verma SK; Mackie AR; Khan M; Arumugam S; Watanabe K; Kishore R; Krishnamurthy P
    Exp Dermatol; 2015 Oct; 24(10):773-8. PubMed ID: 26010430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT6 Acts as a Negative Regulator in Dengue Virus-Induced Inflammatory Response by Targeting the DNA Binding Domain of NF-κB p65.
    Li P; Jin Y; Qi F; Wu F; Luo S; Cheng Y; Montgomery RR; Qian F
    Front Cell Infect Microbiol; 2018; 8():113. PubMed ID: 29686974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.
    Zheng J; Kong C; Yang X; Cui X; Lin X; Zhang Z
    BMC Cancer; 2017 Jun; 17(1):432. PubMed ID: 28629334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis.
    Johnsen IK; Kappler R; Auernhammer CJ; Beuschlein F
    Cancer Res; 2009 Jul; 69(14):5784-92. PubMed ID: 19584291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation.
    Wang W; Wang J
    Med Sci Monit; 2018 Aug; 24():5588-5597. PubMed ID: 30098292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.